Literature DB >> 7684669

Thymomas. Current experience and future directions in therapy.

P J Loehrer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 7684669     DOI： 10.2165/00003495-199345040-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  52 in total

1.  Effectiveness of interleukin-2 in invasive lymphoepithelial thymoma.

Authors:  P Berthaud; T Le Chevalier; T Tursz
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

2.  Induction of natural killer effectors from human thymus with recombinant IL-2.

Authors:  J M Michon; M A Caligiuri; S M Hazanow; H Levine; S F Schlossman; J Ritz
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

3.  The role of radiotherapy in the management of malignant thymoma.

Authors:  C R Penn; H F Hope-Stone
Journal:  Br J Surg       Date:  1972-07       Impact factor: 6.939

Review 4.  Cytolytic T lymphocytes.

Authors:  M Nabholz; H R MacDonald
Journal:  Annu Rev Immunol       Date:  1983       Impact factor: 28.527

5.  Chemotherapy of invasive thymoma.

Authors:  A Fornasiero; O Daniele; C Ghiotto; F Sartori; F Rea; M Piazza; L Fiore-Donati; P Morandi; S M Aversa; A Paccagnella
Journal:  J Clin Oncol       Date:  1990-08       Impact factor: 44.544

6.  Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide.

Authors:  P J Loehrer; R Lauer; B J Roth; S D Williams; L A Kalasinski; L H Einhorn
Journal:  Ann Intern Med       Date:  1988-10-01       Impact factor: 25.391

7.  Thymoma: a continuing survey at the Massachusetts General Hospital.

Authors:  E W Wilkins; B Castleman
Journal:  Ann Thorac Surg       Date:  1979-09       Impact factor: 4.330

8.  Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection.

Authors:  W J Curran; M J Kornstein; J J Brooks; A T Turrisi
Journal:  J Clin Oncol       Date:  1988-11       Impact factor: 44.544

9.  Metastatic thymoma with myasthenia gravis: complete remission with combination chemotherapy.

Authors:  W M Butler; L F Diehl; H G Taylor; M D Weltz
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

10.  Human thymoma: immunologic characteristics of the lymphocytic component.

Authors:  L Lauriola; N Maggiano; M Marino; A Carbone; M Piantelli; P Musiani
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.